Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
18.62
+0.39 (2.14%)
At close: Oct 15, 2025, 4:00 PM EDT
18.62
0.00 (0.00%)
After-hours: Oct 15, 2025, 4:10 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.40 billion as of October 15, 2025. Its market cap has increased by 58.61% in one year.
Market Cap
1.40B
Enterprise Value
1.08B
1-Year Change
58.61%
Ranking
Category
Stock Price
$18.62
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.40B, an increase of 324.89%. That is a compound annual growth rate of 18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 1.37B | 35.89% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |